IRIS
GIACOPPO, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.407
AS - Asia 2.300
EU - Europa 1.257
SA - Sud America 370
AF - Africa 128
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.467
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.329
SG - Singapore 946
CN - Cina 684
RU - Federazione Russa 549
IT - Italia 377
BR - Brasile 303
KR - Corea 213
VN - Vietnam 159
BD - Bangladesh 129
FR - Francia 70
UA - Ucraina 59
HK - Hong Kong 53
IE - Irlanda 45
CA - Canada 43
NG - Nigeria 37
BJ - Benin 29
IN - India 29
NL - Olanda 29
CI - Costa d'Avorio 26
FI - Finlandia 26
AR - Argentina 25
GB - Regno Unito 23
MX - Messico 22
ZA - Sudafrica 14
ES - Italia 13
DE - Germania 12
IQ - Iraq 12
ID - Indonesia 11
TR - Turchia 11
AT - Austria 10
EC - Ecuador 9
PL - Polonia 9
SE - Svezia 9
CO - Colombia 8
CL - Cile 7
JP - Giappone 7
VE - Venezuela 7
IR - Iran 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
JM - Giamaica 5
KE - Kenya 5
PK - Pakistan 5
PY - Paraguay 5
AZ - Azerbaigian 4
CH - Svizzera 4
EG - Egitto 4
BE - Belgio 3
BY - Bielorussia 3
JO - Giordania 3
LT - Lituania 3
PE - Perù 3
PH - Filippine 3
UZ - Uzbekistan 3
AL - Albania 2
BG - Bulgaria 2
IL - Israele 2
NI - Nicaragua 2
SA - Arabia Saudita 2
SI - Slovenia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AU - Australia 1
BO - Bolivia 1
CG - Congo 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GL - Groenlandia 1
GR - Grecia 1
HN - Honduras 1
KH - Cambogia 1
KI - Kiribati 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LS - Lesotho 1
LV - Lettonia 1
LY - Libia 1
MG - Madagascar 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
MQ - Martinica 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 6.467
Salva come PNG Salva come JPEG
Città #
Singapore 499
Dallas 449
Santa Clara 447
Hefei 352
San Jose 309
Moscow 219
Seoul 210
Ashburn 168
Civitanova Marche 120
Chicago 104
Boardman 77
Los Angeles 72
Jacksonville 64
Lauterbourg 61
Hong Kong 51
Beijing 49
Ho Chi Minh City 46
Dublin 45
Buffalo 39
Catania 38
São Paulo 38
New York 37
Milan 33
Chandler 32
Hanoi 31
Cotonou 29
Council Bluffs 28
Lagos 27
Abidjan 26
Lappeenranta 21
Nanjing 21
Orem 17
Rome 17
San Giovanni la Punta 16
Toronto 16
Amsterdam 13
Andover 13
Houston 13
Lawrence 13
Cambridge 12
Naples 11
Palermo 11
Montreal 10
Abuja 9
Boston 9
Brooklyn 9
Chennai 9
Phoenix 9
Warsaw 9
Mexico City 8
Redondo Beach 8
San Mateo 8
Biên Hòa 7
Denver 7
Johannesburg 7
London 7
San Francisco 7
Tokyo 7
Turin 7
Wilmington 7
Bari 6
Frankfurt am Main 6
Haiphong 6
Mascalucia 6
Ottawa 6
Poplar 6
Porto Alegre 6
Rio de Janeiro 6
Salvador 6
Tehran 6
Ankara 5
Atlanta 5
Brasília 5
Charlotte 5
Curitiba 5
Da Nang 5
Des Moines 5
Elk Grove Village 5
Hebei 5
Helsinki 5
Jiaxing 5
Paris 5
Shenyang 5
Stockholm 5
Tianjin 5
Baghdad 4
Bernareggio 4
Bắc Ninh 4
Campinas 4
Can Tho 4
Dong Ket 4
Florence 4
Guayaquil 4
Huế 4
Kingston 4
Madrid 4
Messina 4
Nanchang 4
Querétaro 4
Sorocaba 4
Totale 4.233
Salva come PNG Salva come JPEG
Nome #
Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke : JACC State-of-the-Art Review 157
Pharmacological and Clinical Appraisal of Factor XI Inhibitor Drugs. 147
Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography in the Guidance of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis. 146
Characteristics and Impact of Randomized Trials on Drugs or Devices in Cardiovascular Medicine 116
Targeting Inflammation After Acute Myocardial Infarction 112
PCSK9 inhibitors: current status and emerging frontiers in lipid control 110
Completeness, timing, and guidance of percutaneous coronary intervention for myocardial infarction and multivessel disease: a systematic review and network meta-analysis 110
Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and Prospects 109
Current Management of In-Stent Restenosis 108
Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry) 108
Temporal patterns of early neointimal strut coverage of the CATANIA stent compared with drug eluting stents and bare metal stent: the Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial 107
A pairwise and network meta-analysis of anti-inflammatory strategies after myocardial infarction: the TITIAN study 101
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology. 97
Spontaneous coronary artery dissection 97
Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence from a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients 95
Antiplatelet Therapy in Patients Requiring Oral Anticoagulation and Undergoing Percutaneous Coronary Intervention 94
Anticoagulation After Transcatheter Aortic Valve Replacement 94
Dual antiplatelet therapy de-escalation by discontinuation in patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis 93
Response by Giacoppo et al to Letter Regarding Article “Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis” 92
Short and mid-term benefits of coronary stent system with nanothin Polyzene-F in acute coronary syndromes: preliminary result 91
Association between surgical risk and 30‐day stroke after transcatheter versus surgical aortic valve replacement: a systematic review and meta‐analysis. 90
Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis 88
Coronary Drug-Coated Balloons for De Novo and In-Stent Restenosis Indications. 88
Current developments in dual antiplatelet therapy after stenting 88
Mid-term clinical outcome of Catania coronary stent system with nanothin Polyzene-F in a real world unselected population: preliminary results 88
Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical Trials. 87
Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients. 87
Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Do Bleeding and Stent Thrombosis Weigh Similar on Mortality? 86
Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry 86
Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis. 85
Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial 85
Changes in high-sensitivity troponin after drug-coated balloon angioplasty for drug-eluting stent restenosis. 84
Acute kidney injury after endovascular interventions for critical limb ischemia: Is that a whole different animal? 83
Usefulness of the logistic clinical SYNTAX score for predicting 1-year mortality in patients undergoing percutaneous coronary intervention of the left main coronary artery 83
Changes in Coagulation Factor XI Activity Levels in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI 82
Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention. 82
Meta-Analysis of Short vs. Prolonged Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation and Role of Continuation with either Aspirin or a P2Y12 Inhibitor Thereafter 79
Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis. 79
Management of Patients Treated With Oral Anticoagulant Therapy Undergoing Percutaneous Coronary Intervention With Stent Implantation: The PERSEO Registry 78
Meta-analysis of Randomized Controlled Trials of Preprocedural Statin Administration for Reducing Contrast Induced Acute Kidney In Patients Undergoing Coronary Catheterization 77
Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials 76
Five‐year follow‐up of polymer‐free sirolimus‐ and probucol‐eluting stents versus new generation zotarolimus‐eluting stents in patients presenting with st‐elevation myocardial infarction 75
Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study). 75
Safety and efficacy of minimalist transcatheter aortic valve implantation using a new-generation balloon-expandable transcatheter heart valve in bicuspid and tricuspid aortic valves. 74
Evaluation of a Low-Dose Radiation Protocol During Transcatheter Aortic Valve Implantation 73
Do outcomes following intervention for drug-eluting stent restenosis depend on whether the restenosed stent was polymer-free or polymer-coated? 73
Mid-term clinical outcome of CATANIA Coronary stent system with nanothin Polyzene-F in a real world unselected population: preliminary results 73
Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial. 71
Management of in-stent restenosis 71
Angiographic and clinical outcomes of patients treated with drug-coated balloon angioplasty for in-stent restenosis after coronary bifurcation stenting with a two-stent technique. 70
Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysis. 69
Vascular response to percutaneous coronary intervention with biodegradable-polymer vs. new-generation durable-polymer drug-eluting stents: a meta-analysis of optical coherence tomography imaging trials 67
Expanding indications for drug-coated balloons in coronary artery disease 66
Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials. 65
One-month DAPT after biodegradable-polymer everolimus-eluting stent implantation in patients at high-bleeding risk: an individual patient data pooled analysis of the SENIOR and POEM trials 64
Long-Term Antithrombotic Therapy in Patients with Atrial Fibrillation and Percutaneous Coronary Intervention 62
P2Y 12 inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials 61
Intraindividual Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Drug-Eluting Metallic Stents 61
Anti-inflammatory pharmacotherapy in patients with cardiovascular disease 60
Transcatheter versus surgical aortic valve replacement in the digital era: Meta‐analysis based on the reconstruction of time‐to‐event individual patient data. 60
Management of myocardial revascularisation failure: an expert consensus document of the EAPCI 60
Drug-Coated Balloon Versus Plain Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease. 59
Risk of stroke, atrial fibrillation, and major bleeding after mitral valve repair: the jury is still out. 59
The Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial 59
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis. 59
Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents. 59
Prasugrel monotherapy versus standard DAPT in STEMI patients with OCT-guided or angio-guided complete revascularisation: design and rationale of the randomised, multifactorial COMPARE STEMI ONE trial 56
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents. 55
Advances in the Detection and Management of Vulnerable Coronary Plaques 54
Optimal periprocedural antithrombotic therapy in percutaneous coronary intervention: Between a rock and a hard place? 54
Untangling the knot of the best endovascular treatment for femoropopliteal artery disease 54
Prognostic Value of Cardiac Troponin T and Sex in Patients Undergoing Elective Percutaneous Coronary Intervention 54
Incidence and impact of acute kidney injury in patients with acute coronary syndromes treated with coronary artery bypass grafting: Insights from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) and Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trials 53
Koronare Herzerkrankung mit Hauptstammbeteiliung 52
Reply: Completeness or complexity? A nuanced reflection on multivessel revascularisation 52
Long-term effectiveness and safety of transcatheter closure of patent foramen ovale compared with antithrombotic therapy alone: a meta-analysis of six randomised clinical trials and 3,560 patients with reconstructed time-to-event data 51
Impact of stent size on angiographic and clinical outcomes after implantation of everolimus-eluting bioresorbable scaffolds in daily practice: insights from the ISAR-ABSORB registry 51
Trends in transcatheter aortic valve implantation practice and clinical outcomes at an Irish tertiary referral centre 48
Paclitaxel- or sirolimus-coated balloons for coronary bifurcations: is the side branch SPACIOUS enough for both? 46
Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study 46
Gli stent coronarici a rilascio di farmaco nella pratica interventistica contemporanea: progetto STENT PANORAMA (Parte I) 44
High-risk percutaneous coronary intervention in patients with reduced left ventricular ejection fraction deemed not suitable for surgical revascularisation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the ESC Working Group on Cardiovascular Surgery 44
Predicting the risk of in-stent restenosis after drug-eluting stent implantation: Pipe dream or machine learning-enabled opportunity? 43
Off TARGET Effects in Stent Comparison Trials 35
Radial artery access among mainstays of contemporary percutaneous coronary intervention: Is it time to forget how to puncture a femoral artery? 34
Molecular multimodality imaging: has a long-standing dream come true? 28
Impact of bystander-initiated cardiopulmonary resuscitation for out-of-hospital cardiac arrest: where would you be happy to have a cardiac arrest? 25
Totale 6.569
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.481
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.481
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/202290 12 13 1 0 16 0 13 6 10 0 2 17
2022/2023127 12 1 1 9 20 21 0 18 40 1 0 4
2023/2024246 1 14 4 14 1 10 0 70 12 14 63 43
2024/20251.483 16 174 53 137 328 200 72 30 99 105 92 177
2025/20264.430 350 595 542 265 598 686 405 123 169 215 398 84
Totale 6.569